| scholarly article | Q13442814 |
| P50 | author | Richard Doty | Q7325253 |
| Yaakov Stern | Q46943072 | ||
| Richard Mayeux | Q56850430 | ||
| Elan D Louis | Q66933976 | ||
| Jennifer J Manly | Q90481608 | ||
| Seonjoo Lee | Q96047186 | ||
| P2093 | author name string | Nicole Schupf | |
| Howard Andrews | |||
| D P Devanand | |||
| Laura B Zahodne | |||
| P2860 | cites work | The influences of age on olfaction: a review | Q30442659 |
| Effects of age on the glucose metabolic changes in mild cognitive impairment | Q33931288 | ||
| A 10-item smell identification scale related to risk for Alzheimer's disease | Q33988161 | ||
| Olfactory identification deficits and MCI in a multi-ethnic elderly community sample | Q34161979 | ||
| Smell identification ability: changes with age. | Q34262491 | ||
| Prevalence of olfactory impairment in older adults | Q34528835 | ||
| Age and diagnostic performance of Alzheimer disease CSF biomarkers. | Q35758640 | ||
| The relationship between cerebral Alzheimer's disease pathology and odour identification in old age. | Q36227293 | ||
| Frequency and course of mild cognitive impairment in a multiethnic community | Q36643547 | ||
| Olfaction and the 5-year incidence of cognitive impairment in an epidemiological study of older adults | Q36983697 | ||
| Combining early markers strongly predicts conversion from mild cognitive impairment to Alzheimer's disease | Q37036765 | ||
| APOE epsilon 4 allele predicts faster cognitive decline in mild Alzheimer disease | Q37178272 | ||
| Brain morphology in older African Americans, Caribbean Hispanics, and whites from northern Manhattan | Q37216428 | ||
| Neuropathology of nondemented aging: presumptive evidence for preclinical Alzheimer disease | Q37332710 | ||
| Neuropathologic basis of age-associated brain atrophy. | Q37503283 | ||
| Do neuropsychological tests have the same meaning in Spanish speakers as they do in English speakers? | Q37537701 | ||
| Olfactory identification and incidence of mild cognitive impairment in older age. | Q38396261 | ||
| Odor identification and decline in different cognitive domains in old age. | Q38410593 | ||
| Cortical ¹¹C-PIB uptake is associated with age, APOE genotype, and gender in "healthy aging". | Q39236818 | ||
| Index for rating diagnostic tests | Q39605675 | ||
| Implementing diagnostic criteria and estimating frequency of mild cognitive impairment in an urban community | Q39736209 | ||
| Impaired olfaction as a marker for cognitive decline: interaction with apolipoprotein E epsilon4 status | Q40792548 | ||
| Estimation and Comparison of Receiver Operating Characteristic Curves | Q42249600 | ||
| Apolipoprotein epsilon4 is associated with more rapid decline in odor identification than in odor threshold or Dementia Rating Scale scores | Q43982877 | ||
| Odor identification deficit predicts clinical conversion from mild cognitive impairment to dementia due to Alzheimer's disease | Q44131513 | ||
| Association of olfactory dysfunction with incidental Lewy bodies | Q48415655 | ||
| Study of Mini-Mental State Exam evolution in community-dwelling subjects aged over 60 years without dementia. | Q50597467 | ||
| Dietary antioxidants and Parkinson disease. The Rotterdam Study. | Q50950498 | ||
| Odor identification deficit as a predictor of five-year global cognitive change: interactive effects with age and ApoE-epsilon4. | Q51865514 | ||
| Olfactory identification is impaired in clinic-based patients with vascular dementia and senile dementia of Alzheimer type. | Q51966520 | ||
| Motor impairment in PD: relationship to incident dementia and age. | Q51974672 | ||
| Diagnosis of dementia in a heterogeneous population. Development of a neuropsychological paradigm-based diagnosis of dementia and quantified correction for the effects of education. | Q52075881 | ||
| Presence of both odor identification and detection deficits in Alzheimer's disease. | Q53193962 | ||
| Olfaction in patients with mild cognitive impairment and Alzheimer's disease. | Q53284084 | ||
| Impaired olfaction predicts cognitive decline in nondemented older adults. | Q53672345 | ||
| Internal consistency reliability of the fractionated and whole University of Pennsylvania Smell Identification Test | Q55966793 | ||
| Pathologic Changes in the Olfactory System in Aging and Alzheimer's Diseasea | Q67831679 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Alzheimer's disease | Q11081 |
| dementia | Q83030 | ||
| P304 | page(s) | 182-189 | |
| P577 | publication date | 2014-12-03 | |
| P1433 | published in | Neurology | Q1161692 |
| P1476 | title | Olfactory deficits predict cognitive decline and Alzheimer dementia in an urban community | |
| P478 | volume | 84 |
| Q64786956 | Q64786956 |
| Q90299307 | A meta-analysis of neuropsychological, social cognitive, and olfactory functioning in the behavioral and language variants of frontotemporal dementia |
| Q36456087 | Association Between Olfactory Dysfunction and Amnestic Mild Cognitive Impairment and Alzheimer Disease Dementia |
| Q47370498 | Association between olfaction and higher cortical functions in Alzheimer's disease, mild cognitive impairment, and healthy older adults |
| Q90638229 | Behavioral and Neurobiological Convergence of Odor, Mood and Emotion: A Review |
| Q47231236 | Change in Odor Identification Impairment is Associated with Improvement with Cholinesterase Inhibitor Treatment in Mild Cognitive Impairment |
| Q98292280 | Classifying dementia progression using microbial profiling of saliva |
| Q48137093 | Comparison of odor identification among amnestic and non-amnestic mild cognitive impairment, subjective cognitive decline, and early Alzheimer's dementia |
| Q36788523 | Decline in Weight and Incident Mild Cognitive Impairment: Mayo Clinic Study of Aging |
| Q30658884 | Detecting dementia in patients with normal neuropsychological screening by Short Smell Test and Palmo-Mental Reflex Test: an observational study. |
| Q88062378 | Detection of neurodegenerative disease using olfaction |
| Q55177213 | Development of a High-Sensitivity Method for the Measurement of Human Nasal Aβ42, Tau, and Phosphorylated Tau. |
| Q54943135 | Difference in Subjective Accessibility of On Demand Recall of Visual, Taste, and Olfactory Memories. |
| Q38743202 | Disrupted Olfactory Integration in Schizophrenia: Functional Connectivity Study. |
| Q36172677 | Does Sensory Function Decline Independently or Concomitantly with Age? Data from the Baltimore Longitudinal Study of Aging |
| Q56531759 | Donepezil Treatment in Patients With Depression and Cognitive Impairment on Stable Antidepressant Treatment: A Randomized Controlled Trial |
| Q52147742 | Early in vivo Effects of the Human Mutant Amyloid-β Protein Precursor (hAβPPSwInd) on the Mouse Olfactory Bulb. |
| Q97523300 | Effect of A/T/N imaging biomarkers on impaired odor identification in Alzheimer's disease |
| Q38815351 | Episodic memory of odors stratifies Alzheimer biomarkers in normal elderly |
| Q50034406 | Expression Profiling of Cytokine, Cholinergic Markers, and Amyloid-β Deposition in the APPSWE/PS1dE9 Mouse Model of Alzheimer's Disease Pathology. |
| Q40411081 | Factors Associated with Inaccurate Self-Reporting of Olfactory Dysfunction in Older US Adults |
| Q89493939 | Fimbria-Fornix Volume Is Associated With Spatial Memory and Olfactory Identification in Humans |
| Q55692057 | Hippocampal projections to the anterior olfactory nucleus differentially convey spatiotemporal information during episodic odour memory. |
| Q64261894 | Impaired olfaction is associated with cognitive decline and neurodegeneration in the brain |
| Q41953682 | Increased Regenerative Capacity of the Olfactory Epithelium in Niemann-Pick Disease Type C1. |
| Q98188937 | Increased prediction value of biomarker combinations for the conversion of mild cognitive impairment to Alzheimer's dementia |
| Q64108595 | Long-Term Test-Retest Reliability of the UPSIT in Cognitively Intact Older Adults |
| Q58698198 | Longitudinal Performance of Senescence Accelerated Mouse Prone-Strain 8 (SAMP8) Mice in an Olfactory-Visual Water Maze Challenge |
| Q93211295 | Multiple Sensory Impairment Is Associated With Increased Risk of Dementia Among Black and White Older Adults |
| Q38597149 | Near-infrared spectroscopy (NIRS) and vagus somatosensory evoked potentials (VSEP) in the early diagnosis of Alzheimer's disease: rationale, design, methods, and first baseline data of the Vogel study |
| Q36947147 | Neurogenesis, Neurodegeneration, Interneuron Vulnerability, and Amyloid-β in the Olfactory Bulb of APP/PS1 Mouse Model of Alzheimer's Disease. |
| Q50980528 | Neuroimaging biomarkers and impaired olfaction in cognitively normal individuals. |
| Q88256197 | Odor Identification Ability Predicts PET Amyloid Status and Memory Decline in Older Adults |
| Q35671009 | Odor identification and Alzheimer disease biomarkers in clinically normal elderly |
| Q41545976 | Odor identification as a biomarker of preclinical AD in older adults at risk |
| Q88954425 | Odorant Item Specific Olfactory Identification Deficit May Differentiate Alzheimer Disease From Aging |
| Q38798859 | Olfaction Is Related to Motor Function in Older Adults |
| Q40401284 | Olfaction and risk of dementia in a biracial cohort of older adults |
| Q92584149 | Olfaction in Homozygous and Heterozygous SYNJ1 Arg258Gln Mutation Carriers |
| Q47614469 | Olfactory Dysfunction Predicts Subsequent Dementia in Older U.S. Adults |
| Q64866924 | Olfactory Dysfunction in Neurodegenerative Diseases |
| Q38840463 | Olfactory Function and Associated Clinical Correlates in Former National Football League Players. |
| Q39286812 | Olfactory Identification Deficits, Cognitive Decline, and Dementia in Older Adults |
| Q90372683 | Olfactory and other sensory impairments in Alzheimer disease |
| Q39251022 | Olfactory disturbances in ageing with and without dementia: towards new diagnostic tools |
| Q26752969 | Olfactory dysfunction in Alzheimer's disease |
| Q48227413 | Olfactory dysfunction in the APP/PS1 transgenic mouse model of Alzheimer's disease: Morphological evaluations from the nose to the brain. |
| Q57126675 | Olfactory function and neurocognitive outcomes in old age: The Atherosclerosis Risk in Communities Neurocognitive Study |
| Q64057713 | Olfactory function is associated with cognitive performance: results from the population-based LIFE-Adult-Study |
| Q50577989 | Olfactory identification deficit predicts white matter tract impairment in Alzheimer's disease. |
| Q28386484 | Olfactory identification deficits and increased mortality in the community |
| Q45328263 | Olfactory identification in subjective cognitive decline and mild cognitive impairment: Association with tau but not amyloid positron emission tomography |
| Q30642884 | Olfactory impairment and traumatic brain injury in blast-injured combat troops: a cohort study |
| Q49888050 | Optimizing olfactory testing for the diagnosis of Parkinson's disease: item analysis of the university of Pennsylvania smell identification test |
| Q60054319 | Perspectives of General Practitioners on the Issues Surrounding the Late Diagnosis of Alzheimer's Disease |
| Q40278008 | Phantom Smells: Prevalence and Correlates in a Population-Based Sample of Older Adults |
| Q36477318 | Reduction of Glucose Metabolism in Olfactory Bulb is an Earlier Alzheimer's Disease-related Biomarker in 5XFAD Mice |
| Q47250449 | Relation of Odor Identification with Alzheimer's Disease Markers in Cerebrospinal Fluid and Cognition |
| Q47865513 | Relationships Between Lower Olfaction and Brain White Matter Lesions in Elderly Subjects with Mild Cognitive Impairment. |
| Q47728112 | SMELL-S and SMELL-R: Olfactory tests not influenced by odor-specific insensitivity or prior olfactory experience |
| Q38774726 | Sensorineural Organs Dysfunction and Cognitive Decline: A Review Article |
| Q38741864 | Smell Loss Predicts Mortality Risk Regardless of Dementia Conversion |
| Q33576727 | Study protocol: Insight 46 - a neuroscience sub-study of the MRC National Survey of Health and Development |
| Q47726069 | Symptoms associated with Lewy body disease in mild cognitive impairment |
| Q28607743 | The Cooperative Health Research in South Tyrol (CHRIS) study: rationale, objectives, and preliminary results |
| Q38498842 | The role of DNA base excision repair in brain homeostasis and disease. |
| Q37497045 | Traditional Chinese Medicine Huannao Yicong Decoction Extract Decreases Tau Hyperphosphorylation in the Brain of Alzheimer's Disease Model Rats Induced by Aβ1-42. |
| Q88678135 | Variability and Coupling of Olfactory Identification and Episodic Memory in Older Adults |
| Q52682109 | Visualization of Altered Hippocampal Connectivity in an Animal Model of Alzheimer's Disease. |
Search more.